Latest filing published 29 Dec 2023 for Catalyst Pharmaceuticals, INC.. Read the official filing
All filings by Alicia Grande on record concern Catalyst Pharmaceuticals, Inc., in the capacity of finance chief. The record holds 18 filings, for trades running from 17 August 2021 to 27 December 2023.
Sales make up the whole of the open-market record (9 sales, €6.5M). Other entries cover 9 option exercises.
The newest entry dates from 29 December 2023: an option exercise, in Catalyst Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
18 of 18 declarations